The Short Answer
Tesamorelin is a lab-made version of growth hormone-releasing hormone (GHRH). It signals the pituitary gland to release more of the body's own growth hormone, which raises IGF-1.
It is FDA-approved (brand name Egrifta) for one use: reducing excess abdominal (visceral) fat in adults with HIV who have lipodystrophy. It is not approved for general weight loss, bodybuilding or anti-aging.
This is an educational guide. It doesn't give dosing advice. Talk with a licensed clinician about whether any treatment is right for you.
What the Trials Found
| Outcome | What was reported | Source |
|---|---|---|
| Visceral (deep belly) fat | About 15% reduction vs placebo over 26 weeks | Falutz, NEJM 2007; Falutz, JCEM 2010 |
| Liver fat | Modest reduction vs placebo over 6 months | Stanley, JAMA 2014 |
| Triglycerides and cholesterol ratio | Improved vs placebo | Falutz, NEJM 2007; Falutz, JCEM 2010 |
| Subcutaneous (under-skin) belly fat | No significant change | Falutz, JCEM 2010 |
| Longer use | The visceral fat reduction was maintained to 52 weeks with continued treatment | Falutz, JCEM 2010 |
All of these studies were in people with HIV and excess abdominal fat. Results in other groups aren't established.
Does Tesamorelin Build Muscle?
This is one of the fastest-rising tesamorelin searches. The honest answer: tesamorelin was never studied or approved as a muscle-building drug. Its pivotal trials measured belly fat, lipids and body image, not strength or performance. Growth hormone and IGF-1 do affect body composition, but "builds muscle" claims go beyond what these trials tested.
What It Doesn't Do
- It isn't a GLP-1 and doesn't work through appetite the way semaglutide or retatrutide do.
- It doesn't replace growth hormone itself. It depends on a working pituitary.
- It isn't a general "fat burner." Its studied effect is on visceral fat in a specific population.
Safety Notes From the Label and Trials
Reported side effects included injection-site reactions, joint pain, swelling and effects related to raised IGF-1, and clinicians watch blood sugar. Because it raises IGF-1, clinicians monitor labs. Your clinician is the right person to weigh these against your history.
Tracking With Your Clinician
If you're prescribed tesamorelin, consistent notes help your clinician judge whether it's working: injection days and sites, waist measurements, weight, lab dates and any side effects. PeptIQ.io keeps those on one timeline you can share with your care team.
Related reading: Tesamorelin and growth hormone explained and Tesamorelin reconstitution guide.
